Daily SPAC Update – March 11, 2025

by | Mar 11, 2025

USA Rare Earth Deal with Inflection Point Acquisition II Approved. Liminatus Pharma + Iris Acquisition Approved. Aquaron Delisting. SK Growth and Oak Woods Get Vote Dates.

Boardroom Alpha SPAC Resources
– Full SPAC Listing
– SPAC SEC Filings
– Boardroom Alpha IPO & SPAC Intelligence Platform (7-Day Trial)

Daily SPAC Update

SPAC VOTE RESULTS
IPXX – INFLECTION POINT ACQUISITION CORP II * Deal Approved with USA Rare Earth, LLC
IRAA – IRIS ACQUISITION CORP * Deal Approved with Liminatus Pharma LLC * 59,844 redeemed * $686,410.68 removed * trust $11.47

SPAC DEAL & EXTENSION VOTES SET
SKGR – Sk Growth Opportunities Corp * DEAL VOTE SET: Mar 30, 2025 * trust $11.69
OAKU – Oak Woods Acquisition Corp * EXTENSION VOTE SET: Mar 20, 2025 * trust $11.54

OTHER SPAC NEWS
AQU – AQUARON ACQUISITION CORP * Delisting

SEPARATE WARRANTS/RIGHTS
Mar 13: K&F GROWTH ACQUISITION CORP II (KFII)

YESTERDAY’S TOP SPAC GAINERS
2.63% ~ $ 3.90 | BOWN – BOWEN ACQUISITION CORP (Announced)
.40% ~ $ 10.03 | GSRT – GSR III ACQUISITION CORP (Pre-Deal)
.38% ~ $ 10.61 | CCIX – CHURCHILL CAPITAL CORP IX (Pre-Deal)
.38% ~ $ 10.69 | JVSA – JVSPAC ACQUISITION CORP (Announced)
.36% ~ $ 11.19 | KVAC – KEEN VISION ACQUISITION CORP (Announced)

YESTERDAY’S TOP SPAC LOSERS
-16.01% ~ $ 10.91 | IPXX – INFLECTION POINT ACQUISITION CORP II (Announced)
-1.73% ~ $ 11.92 | CLRC – CLIMATEROCK (Announced)
-1.29% ~ $ 10.70 | HLXB – HELIX ACQUISITION CORP II (Announced)
-1.26% ~ $ 10.95 | DMYY – DMY SQUARED TECHNOLOGY GROUP INC (Pre-Deal)
-1.16% ~ $ 11.95 | EVGR – EVERGREEN CORP (Announced)

LATEST SPAC IPO PERFORMANCE
Feb 27 | $ 10.02 | LOKV – Live Oak Acquisition Corp. V
Feb 27 | $ 10.04 | NHIC – NewHold Investment Corp. III
Feb 27 | $ 10.01 | FERA – Fifth Era Acquisition Corp I
Feb 26 | $ 10.05 | RAC – Rithm Acquisition Corp.
Feb 12 | $ 10.04 | AACB – Artius II Acquisition Inc.
Feb 12 | $ 10.12 | MAYA – Maywood Acquisition Corp.
Feb 10 | $ 10.06 | ATII – Archimedes Tech SPAC Partners II Co.

 

Recent Analysis

Daily SPAC Update – March 20, 2026

Another Quantum DeSPAC as DMY becomes Horizon Quantum. Inflection Point III Increases PIPE. UY Scuti Moves Vote Again. Blue Water IV IPOs for $125 Million.

Daily SPAC Update – March 19, 2026

SPAC IPOs Slow as BHAV Acquisition’s IPO Makes it Only 6 for March. Integrated Wellness Extension and Voyager + Veraxa Biotech Deal Approved. Quartzsea Deal Terminated.

Daily SPAC Update – March 18, 2026

DMY Squared’s Quantum Deal Approved. Winvest Acquisition Extension Approved. Pelican Deal Vote Delayed. Alphatime Sets Extension Vote. Cayson Goes to Vote.

Daily SPAC Update – March 17, 2026

Harry You’s DMY Squared Deal Vote with Horizon Quantum Today. Pelican Acquisition Deal Vote. Abra and GNQ Insilico Deals Announced. Merlin DeSPAC.

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.